SUBSTITUTED 1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONES

Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as breast cancer.

Saved in:
Bibliographic Details
Main Authors Liu, Hui, Abraham, Sunny, Paliwal, Sunil, Hegde, Sayee Gajanan, Bunker, Kevin Duane, Unni, Aditya Krishnan, Hopkins, Chad Daniel, Boren, Brant Clayton, Huang, Peter Qinhua
Format Patent
LanguageEnglish
Published 27.01.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

Abstract Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as breast cancer.
AbstractList Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as breast cancer.
Author Boren, Brant Clayton
Hopkins, Chad Daniel
Liu, Hui
Abraham, Sunny
Unni, Aditya Krishnan
Huang, Peter Qinhua
Bunker, Kevin Duane
Hegde, Sayee Gajanan
Paliwal, Sunil
Author_xml – fullname: Liu, Hui
– fullname: Abraham, Sunny
– fullname: Paliwal, Sunil
– fullname: Hegde, Sayee Gajanan
– fullname: Bunker, Kevin Duane
– fullname: Unni, Aditya Krishnan
– fullname: Hopkins, Chad Daniel
– fullname: Boren, Brant Clayton
– fullname: Huang, Peter Qinhua
BookMark eNrjYmDJy89L5WSwCg51Cg7xDAkNcXVRMNQx0nXx9Ih0CfLXNfbQDYgMcozy9_GPNtYx0XWJBXI9fT1dPP10jXX9_VyDeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfGiwkYEREJlYGls6GhoTpwoAZeUrrA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2022024939A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2022024939A13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:50:19 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2022024939A13
Notes Application Number: US202117497355
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220127&DB=EPODOC&CC=US&NR=2022024939A1
ParticipantIDs epo_espacenet_US2022024939A1
PublicationCentury 2000
PublicationDate 20220127
PublicationDateYYYYMMDD 2022-01-27
PublicationDate_xml – month: 01
  year: 2022
  text: 20220127
  day: 27
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies Recurium IP Holdings, LLC
RelatedCompanies_xml – name: Recurium IP Holdings, LLC
Score 3.377297
Snippet Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title SUBSTITUTED 1,2-DIHYDRO-3H-PYRAZOLO[3,4-D]PYRIMIDIN-3-ONES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220127&DB=EPODOC&locale=&CC=US&NR=2022024939A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8BhT1Dedih9TBkqfFmybdDPCkLVp6cS1Y21lU2S0MwVBuuEq_n2vddM97S2Xg-MSuO_cBeC6rasJZTwlqPkkYcYbIxzdfKK1p1yLZdJSyyaxvtdyI_YwMkYV-Fj1wpRzQr_L4YgoUVOU97zU1_P_JJYo31YubpJ33JrdO2FHKMvoWNeLSqoizI498IVvKZbViQLFG_7iMNSgvIux0lbhSBeT9u0ns-hLma8bFWcftgdIL8sPoCKzGuxaq7_XarDTX5a8cbmUvsUh3AWRGYS9MEJt09CaOhE9dyyGPqEuGYyH3Wf_0X-hTUbEK4KolUTPI5T4nh0cwZVjh5ZLkInJ35knUbDOMT2GajbL5Ak0GJtyqqZaoqIjkMYsvlV5LGPKW0ZqaDI9hfomSmeb0eewV4BFjkFv16Gaf37JC7S6eXJZXtYPNiF-6A
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQOlTwu2TboaocjWbLS6tWNtZVNktLMFQbrhKv77Xuume9pbkoPjErjffSR3AbjWVTmijCcEkS8mTHtjhKObTxR9ypUwjppyUSTWd5pWwB5G2qgEH6tamKJP6HfRHBE1aor6nhV4Pf9PYonibeXiJnrHpdl91zeEtIyOVTW_SZVE2-gMXOGakmkagSc5w18ahhqUtzBW2tLz_ry58_TUzutS5utGpbsH2wPkl2b7UIrTKlTM1d9rVdjpL6-8cbjUvsUB3HlB2_NtP0C0qSsNlQjbGouhS6hFBuNh69ntuS-0wYh4xSmikrAdQonrdLxDuOp2fNMiKMTkb8-TwFuXmB5BOZ2l8THUGZtyKidKJKMjkIQsvJV5GIeUN7VEU-LkBGqbOJ1uJl9CxfL7vUnPdh7PYDcn5fkGVa9BOfv8is_RAmfRRXFwP033gdU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SUBSTITUTED+1%2C2-DIHYDRO-3H-PYRAZOLO%5B3%2C4-D%5DPYRIMIDIN-3-ONES&rft.inventor=Liu%2C+Hui&rft.inventor=Abraham%2C+Sunny&rft.inventor=Paliwal%2C+Sunil&rft.inventor=Hegde%2C+Sayee+Gajanan&rft.inventor=Bunker%2C+Kevin+Duane&rft.inventor=Unni%2C+Aditya+Krishnan&rft.inventor=Hopkins%2C+Chad+Daniel&rft.inventor=Boren%2C+Brant+Clayton&rft.inventor=Huang%2C+Peter+Qinhua&rft.date=2022-01-27&rft.externalDBID=A1&rft.externalDocID=US2022024939A1